Abstract

The Phase I Clinical trial units will investigate therapeutic agents for the treatment of infectious diseases. The Phase I units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200800024C-4-0-1
Application #
8320832
Study Section
Project Start
2008-05-30
Project End
2013-05-29
Budget Start
Budget End
Support Year
Fiscal Year
2011
Total Cost
$150,000
Indirect Cost

  Institution

Name
Dynport Vaccine Company, LLC
Department
Type
DUNS #
014130053
City
Frederick
State
MD
Country
United States
Zip Code
21702